Kitahara Tomohiro, Takemasa Ichiro, Inoue Akira, Osawa Hideki, Miyo Masaaki, Mokutani Yukako, Ogawa Hisataka, Naito Atsushi, Hamabe Atsushi, Hiraki Masayuki, Munakata Koji, Uemura Mamoru, Nishimura Junichi, Hata Taishi, Mizushima Tsunekazu, Yamamoto Hirofumi, Doki Yuichiro, Mori Masaki
Dept. of Gastroenterological Surgery, Graduate School of Medicine, Osaka University.
Gan To Kagaku Ryoho. 2014 Nov;41(12):1569-71.
A 70-year-old man presenting with melena was referred to our clinic. A clinical examination revealed a bulky tumor in the lower rectum. After ileostomy, 4 courses of capecitabine plus oxaliplatin (XELOX) therapy were administered as neoadjuvant chemotherapy. Computed tomography (CT) revealed significant reduction of the tumor. Laparoscopic super-low anterior resection with lateral lymph node dissection was performed. The pathological examination revealed no residual cancer cells, and a diagnosis of pathological complete response was made. The patient has been disease-free for 1 year after the operation. Neoadjuvant chemotherapy with XELOX might be promising for patients with locally advanced rectal cancer.